| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | GOLGA6L | 3.12e-08 | 6 | 128 | 4 | IPR026737 | |
| Domain | GOLGA2L5 | 5.98e-06 | 18 | 128 | 4 | PF15070 | |
| Domain | Golgin_A | 5.98e-06 | 18 | 128 | 4 | IPR024858 | |
| Domain | Znf_PHD-finger | 1.70e-05 | 79 | 128 | 6 | IPR019787 | |
| Domain | PHD | 3.36e-05 | 89 | 128 | 6 | SM00249 | |
| Domain | Znf_PHD | 3.81e-05 | 91 | 128 | 6 | IPR001965 | |
| Domain | ZF_PHD_2 | 4.86e-05 | 95 | 128 | 6 | PS50016 | |
| Domain | ZF_PHD_1 | 5.16e-05 | 96 | 128 | 6 | PS01359 | |
| Domain | Glyco_trans_43 | 1.39e-04 | 3 | 128 | 2 | IPR005027 | |
| Domain | Glyco_transf_43 | 1.39e-04 | 3 | 128 | 2 | PF03360 | |
| Domain | PHD | 1.64e-04 | 75 | 128 | 5 | PF00628 | |
| Domain | NUT | 4.60e-04 | 5 | 128 | 2 | IPR024310 | |
| Domain | NUT_N | 4.60e-04 | 5 | 128 | 2 | IPR024309 | |
| Domain | NUT | 4.60e-04 | 5 | 128 | 2 | PF12881 | |
| Domain | Znf_FYVE_PHD | 5.29e-04 | 147 | 128 | 6 | IPR011011 | |
| Domain | AT_hook | 8.15e-04 | 27 | 128 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 8.15e-04 | 27 | 128 | 3 | IPR017956 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NOLC1 ZC3H13 U2SURP DLGAP5 NUTM2A TFIP11 PTBP1 KRR1 CDCA8 HP1BP3 NCBP3 SCML2 NUTM2B ZSCAN21 BAZ2A FEN1 DDX21 MGA NOP2 SLX4 ELL RAI1 DNMT1 | 1.38e-12 | 954 | 131 | 23 | 36373674 |
| Pubmed | AKAP6 NOLC1 ZC3H13 TUT7 DLGAP5 ASH1L APC TFIP11 INO80 KRR1 EHD3 SCML2 ZSCAN21 OSBPL3 NFX1 ANKRD17 AFF1 CPLANE1 KIF13A DDX21 MGA UTRN SLX4 LRRC18 | 2.56e-12 | 1084 | 131 | 24 | 11544199 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NOLC1 FAM193B HAUS6 TCOF1 U2SURP DLGAP5 TFIP11 HP1BP3 TWF1 GPALPP1 SCML2 BAZ2A KIAA1217 CIAPIN1 FEN1 ANKRD17 DDX21 NOP2 UTRN DNMT1 | 3.71e-10 | 934 | 131 | 20 | 33916271 |
| Pubmed | TCOF1 ZC3H13 U2SURP POLRMT TFIP11 INO80 KRR1 AHDC1 HP1BP3 OSBPL3 A2ML1 FEN1 ANKRD17 SLC25A11 HADHB SPATS2 DDX21 NOP2 ELL | 4.95e-10 | 847 | 131 | 19 | 35850772 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NOLC1 TCOF1 ZC3H13 U2SURP DLGAP5 TFIP11 INO80 PTBP1 AHDC1 HP1BP3 CLASRP SCML2 ZSCAN21 USP42 BAZ2A OSBPL3 ISG20L2 HADHB DDX21 MGA NOP2 RAI1 DNMT1 | 5.83e-10 | 1294 | 131 | 23 | 30804502 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | DLGAP5 INO80 CDCA8 HP1BP3 NCBP3 SCML2 TRMT6 ZSCAN21 BAZ2A RAD54B FEN1 UHRF2 MGA NOP2 RAI1 DNMT1 | 1.36e-09 | 608 | 131 | 16 | 36089195 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NOLC1 U2SURP TUT7 DLGAP5 POLRMT TFIP11 DPF2 PTBP1 KRR1 PIK3C2A BAZ2A A2ML1 FEN1 ANKRD17 AKAP13 SLC25A11 HADHB LTF DDX21 MGA NOP2 UTRN DNMT1 | 1.37e-09 | 1353 | 131 | 23 | 29467282 |
| Pubmed | NOLC1 TCOF1 ZC3H13 U2SURP TUT7 POLRMT KRR1 HP1BP3 BAZ2A ANKRD17 LTF DDX21 NOP2 UTRN RAI1 DNMT1 | 3.74e-09 | 653 | 131 | 16 | 22586326 | |
| Pubmed | TCOF1 KALRN DLGAP5 ADGRB3 APC TWF1 EHD3 PTPRN2 OSBPL3 N4BP2 KIAA1217 ANKRD17 SPATS2 BRSK1 MGA NOP2 NOS1 RAI1 DNMT1 | 4.05e-09 | 963 | 131 | 19 | 28671696 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NOLC1 PHACTR2 BAD APC RGS12 TWF1 NHSL1 NKD2 PIK3C2A SH3PXD2A OSBPL3 N4BP2 KIAA1217 ANKRD17 AKAP13 KIF13A UTRN DNMT1 | 4.42e-09 | 861 | 131 | 18 | 36931259 |
| Pubmed | TCOF1 TUT7 NUTM2A TFIP11 PTBP1 KRR1 HP1BP3 NCBP3 TRMT6 PIK3C2A OSBPL3 FEN1 NFX1 ANKRD17 ISG20L2 SLC25A11 HADHB SPATS2 ATP1B1 DDX21 NOP2 DNMT1 | 9.28e-09 | 1371 | 131 | 22 | 36244648 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | HAUS6 APC INO80 SCML2 NECAP2 PIK3C2A SH3PXD2A CIAPIN1 NFX1 ANKRD17 AKAP13 SLC25A11 SPATS2 DDX21 MGA NOP2 | 1.59e-08 | 724 | 131 | 16 | 36232890 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NOLC1 TCOF1 ZC3H13 DLGAP5 TATDN2 TFIP11 DPF2 CLASRP SCML2 USP42 BAZ2A ANKRD17 AFF1 DDX21 NOP2 DNMT1 | 3.99e-08 | 774 | 131 | 16 | 15302935 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | NOLC1 ZC3H13 TUT7 POLRMT PTBP1 KRR1 HP1BP3 TWF1 TRMT6 KIAA1217 FEN1 ANKRD17 SLC25A11 HADHB LTF SPATS2 UHRF2 DDX21 NOP2 DNMT1 | 5.44e-08 | 1257 | 131 | 20 | 36526897 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | NOLC1 TCOF1 ZC3H13 U2SURP TFIP11 PTBP1 KRR1 HP1BP3 NCBP3 LTF SPATS2 DDX21 NOP2 RAI1 | 7.58e-08 | 605 | 131 | 14 | 28977666 |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | TCOF1 U2SURP TATDN2 DPF2 KRR1 HP1BP3 CLASRP ZSCAN21 FEN1 RNF216 SLC25A11 ATP1B1 NOP2 TP73 | 2.61e-07 | 670 | 131 | 14 | 22990118 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | KALRN ADGRB3 APC INO80 GPALPP1 A2ML1 NFX1 SLC25A11 SPATS2 DDX21 NOP2 DNMT1 | 2.68e-07 | 475 | 131 | 12 | 31040226 |
| Pubmed | ASH1L APC DPF2 KRR1 TWF1 NHSL1 TRMT6 NKD2 USP42 OSBPL3 FEN1 AKAP13 HADHB MGA | 3.66e-07 | 689 | 131 | 14 | 36543142 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NOLC1 TCOF1 KALRN ZC3H13 U2SURP APC TFIP11 DPF2 INO80 PTBP1 AHDC1 HP1BP3 USP42 FEN1 SLC25A11 HADHB DDX21 | 7.09e-07 | 1082 | 131 | 17 | 38697112 |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | TUT7 TFIP11 KRR1 AHDC1 KIAA1217 A2ML1 FEN1 ANKRD17 SLC25A11 SPATS2 BRSK1 CPLANE1 DDX21 NOP2 | 7.50e-07 | 732 | 131 | 14 | 34732716 |
| Pubmed | TUT7 DLGAP5 SYTL2 APC SHC4 TFIP11 SCML2 NECAP2 N4BP2 CIAPIN1 ROBO1 AKAP13 MGA DNMT1 | 7.63e-07 | 733 | 131 | 14 | 34672954 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 8.97e-07 | 349 | 131 | 10 | 25665578 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NOLC1 TUT7 POLRMT PTBP1 KRR1 CDCA8 HP1BP3 NCBP3 ISG20L2 SLC25A11 SPATS2 DDX21 NOP2 DNMT1 | 1.15e-06 | 759 | 131 | 14 | 35915203 |
| Pubmed | PCSK5 TUT7 POLRMT APC TFIP11 HP1BP3 OSBPL3 RAD54B ANKRD17 RNF216 AKAP13 SLC25A11 DNMT1 | 1.17e-06 | 650 | 131 | 13 | 38777146 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.37e-06 | 283 | 131 | 9 | 30585729 | |
| Pubmed | NOLC1 U2SURP POLRMT KRR1 HP1BP3 ISG20L2 HADHB LTF SPATS2 DDX21 NOP2 | 2.35e-06 | 483 | 131 | 11 | 36912080 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | NOLC1 TCOF1 ZC3H13 U2SURP TFIP11 PTBP1 KRR1 HP1BP3 GPALPP1 NECAP2 USP42 BAZ2A FEN1 SLC25A11 HADHB DDX21 NOP2 DNMT1 | 2.39e-06 | 1318 | 131 | 18 | 30463901 |
| Pubmed | RAB22A POLRMT APC TFIP11 INO80 KRR1 AHDC1 TWF1 SCML2 PIK3C2A BAZ2A CRACDL NFX1 ANKRD17 ISG20L2 SLC25A11 SPATS2 ATP1B1 UTRN | 3.54e-06 | 1497 | 131 | 19 | 31527615 | |
| Pubmed | TCOF1 U2SURP DPF2 PTBP1 AHDC1 HP1BP3 ANKRD17 HADHB SPATS2 DDX21 NOP2 TP73 | 3.94e-06 | 615 | 131 | 12 | 31048545 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | HAUS6 TUT7 APC RGS12 NECAP2 OSBPL3 N4BP2 KIAA1217 CIAPIN1 NFX1 SLC25A11 CPLANE1 MGA ELL | 4.43e-06 | 853 | 131 | 14 | 28718761 |
| Pubmed | 8.02e-06 | 72 | 131 | 5 | 31248990 | ||
| Pubmed | NOLC1 PHACTR2 MYLK U2SURP RAB22A ASH1L PTBP1 NKIRAS2 PLA2G4D TRDN HP1BP3 GPALPP1 SH3PXD2A N4BP2 ISG20L2 HADHB DDX21 RAI1 | 8.23e-06 | 1442 | 131 | 18 | 35575683 | |
| Pubmed | Knockdown of slit signaling during limb development leads to a reduction in humerus length. | 8.43e-06 | 11 | 131 | 3 | 33347679 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | NOLC1 TCOF1 ZC3H13 U2SURP TUT7 POLRMT PTBP1 KRR1 NCBP3 NFX1 SLC25A11 DDX21 NOP2 | 1.21e-05 | 807 | 131 | 13 | 22681889 |
| Pubmed | TCOF1 U2SURP POLRMT APC PTBP1 HP1BP3 BAZ2A FEN1 ISG20L2 SLC25A11 HADHB DDX21 NOP2 | 1.24e-05 | 809 | 131 | 13 | 32129710 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 7537636 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 11888894 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 22787431 | ||
| Pubmed | Suppressive effect of global DNA hypomethylation on gastric carcinogenesis. | 1.41e-05 | 2 | 131 | 2 | 20622006 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 17935701 | ||
| Pubmed | Reducing DNA methylation suppresses colon carcinogenesis by inducing tumor cell differentiation. | 1.41e-05 | 2 | 131 | 2 | 25939752 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 12538347 | ||
| Pubmed | Human DNA methyltransferase gene DNMT1 is regulated by the APC pathway. | 1.41e-05 | 2 | 131 | 2 | 12538344 | |
| Pubmed | Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. | 1.41e-05 | 2 | 131 | 2 | 16174748 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 26431531 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 29383140 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 32470195 | ||
| Pubmed | The proprotein convertase PC5/6 is protective against intestinal tumorigenesis: in vivo mouse model. | 1.41e-05 | 2 | 131 | 2 | 19737405 | |
| Pubmed | Haploinsufficiency of Flap endonuclease (Fen1) leads to rapid tumor progression. | 1.41e-05 | 2 | 131 | 2 | 12119409 | |
| Pubmed | ApcMin/+ mouse model of colon cancer: gene expression profiling in tumors. | 1.41e-05 | 2 | 131 | 2 | 15486983 | |
| Pubmed | Stromal Cell-SLIT3/Cardiomyocyte-ROBO1 Axis Regulates Pressure Overload-Induced Cardiac Hypertrophy. | 1.41e-05 | 2 | 131 | 2 | 38414132 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 19218431 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 26659409 | ||
| Pubmed | 1.45e-05 | 13 | 131 | 3 | 19700621 | ||
| Pubmed | 1.65e-05 | 486 | 131 | 10 | 20936779 | ||
| Pubmed | NOLC1 TCOF1 U2SURP BAD APC TFIP11 PTBP1 AHDC1 PIK3C2A ANKRD17 AFF1 SLC25A11 HADHB SPATS2 DDX21 MGA | 1.96e-05 | 1247 | 131 | 16 | 27684187 | |
| Pubmed | PCSK5 FAM193B KALRN PTBP1 TCEANC AHDC1 CLASRP TDRD7 NUTM2B PTPRN2 CYB5R1 | 2.04e-05 | 608 | 131 | 11 | 16713569 | |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 2.18e-05 | 221 | 131 | 7 | 29991511 | |
| Pubmed | NOLC1 TCOF1 ZC3H13 U2SURP TFIP11 PTBP1 KRR1 HP1BP3 ISG20L2 SLC25A11 DDX21 NOP2 | 2.21e-05 | 731 | 131 | 12 | 29298432 | |
| Pubmed | NOLC1 HAUS6 TCOF1 KALRN ZC3H13 DLGAP5 APC AKAP13 KIF13A NOP2 | 2.22e-05 | 503 | 131 | 10 | 16964243 | |
| Pubmed | 2.33e-05 | 506 | 131 | 10 | 30890647 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 2.69e-05 | 410 | 131 | 9 | 26949251 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 3.62e-05 | 533 | 131 | 10 | 30554943 | |
| Pubmed | 3.72e-05 | 329 | 131 | 8 | 17474147 | ||
| Pubmed | NOLC1 HAUS6 TCOF1 APC PTBP1 HP1BP3 CTDSP2 NECAP2 ROBO1 MGA NOP2 DNMT1 | 3.99e-05 | 777 | 131 | 12 | 35844135 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 10102269 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 27237979 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 22003386 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 11872162 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 34897340 | ||
| Pubmed | Mechanism of adenomatous polyposis coli (APC)-mediated blockage of long-patch base excision repair. | 4.21e-05 | 3 | 131 | 2 | 17176113 | |
| Pubmed | Reduction of pancreatic acinar cell tumor multiplicity in Dnmt1 hypomorphic mice. | 4.21e-05 | 3 | 131 | 2 | 21362628 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 20720107 | ||
| Pubmed | Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin. | 4.21e-05 | 3 | 131 | 2 | 20483958 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 30394818 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 20687897 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 26483274 | ||
| Pubmed | The clinical phenotype of YWHAE-NUTM2B/E positive pediatric clear cell sarcoma of the kidney. | 4.21e-05 | 3 | 131 | 2 | 26542179 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 22456610 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 25738352 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 27533450 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 31469403 | ||
| Pubmed | Tumor progression in Apc(1638N) mice with Exo1 and Fen1 deficiencies. | 4.21e-05 | 3 | 131 | 2 | 17452984 | |
| Pubmed | Osteoclast-secreted SLIT3 coordinates bone resorption and formation. | 4.21e-05 | 3 | 131 | 2 | 29504949 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 15604408 | ||
| Pubmed | 4.27e-05 | 167 | 131 | 6 | 35833506 | ||
| Pubmed | NOLC1 TCOF1 ZC3H13 POLRMT TFIP11 HP1BP3 NCBP3 ATF6 PIK3C2A BAZ2A N4BP2 ROBO1 AKAP13 HADHB DDX21 NOP2 DNMT1 | 4.54e-05 | 1487 | 131 | 17 | 33957083 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 BAD ASH1L AHDC1 HP1BP3 EHD3 ATF6 PTPRN2 SH3PXD2A KIAA1217 ANKRD17 AFF1 AKAP13 KATNIP SPATS2 UTRN RAI1 | 4.61e-05 | 1489 | 131 | 17 | 28611215 |
| Pubmed | 4.72e-05 | 441 | 131 | 9 | 31239290 | ||
| Pubmed | 4.78e-05 | 551 | 131 | 10 | 34728620 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 4.78e-05 | 341 | 131 | 8 | 32971831 | |
| Pubmed | NOLC1 PCSK5 FAM193B PHACTR2 ZC3H13 TUT7 ASH1L AHDC1 CTDSP2 SH3PXD2A RAD54B FEN1 TOR1B SPATS2 UTRN | 5.60e-05 | 1215 | 131 | 15 | 15146197 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | NOLC1 TCOF1 U2SURP SHC4 PTBP1 HP1BP3 TWF1 OSBPL3 FEN1 SLC25A11 LTF DDX21 NOP2 | 6.42e-05 | 949 | 131 | 13 | 36574265 |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | TCOF1 APC PTBP1 KRR1 CLASRP NCBP3 AFF1 LTF SPATS2 DDX21 NOP2 | 6.81e-05 | 695 | 131 | 11 | 23602568 |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 7.12e-05 | 361 | 131 | 8 | 30344098 | |
| Pubmed | 7.38e-05 | 268 | 131 | 7 | 33640491 | ||
| Pubmed | NOLC1 U2SURP DPF2 PTBP1 AHDC1 GPALPP1 ZSCAN21 CIAPIN1 FEN1 HADHB UHRF2 NOP2 RAI1 DNMT1 | 7.50e-05 | 1103 | 131 | 14 | 34189442 | |
| Pubmed | 7.56e-05 | 469 | 131 | 9 | 27634302 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 7.92e-05 | 271 | 131 | 7 | 32433965 | |
| Pubmed | 8.06e-05 | 116 | 131 | 5 | 21282530 | ||
| Interaction | SMC5 interactions | NOLC1 ZC3H13 U2SURP DLGAP5 NUTM2A TFIP11 PTBP1 KRR1 CDCA8 HP1BP3 NCBP3 SCML2 NUTM2B ZSCAN21 BAZ2A FEN1 DDX21 MGA NOP2 SLX4 ELL RAI1 DNMT1 | 4.68e-08 | 1000 | 125 | 23 | int:SMC5 |
| Interaction | H3C3 interactions | DLGAP5 CDCA8 HP1BP3 NCBP3 SCML2 TRMT6 ZSCAN21 BAZ2A RAD54B FEN1 UHRF2 MGA NOP2 RAI1 DNMT1 | 4.41e-07 | 495 | 125 | 15 | int:H3C3 |
| Interaction | NAA40 interactions | NOLC1 FAM193B HAUS6 TCOF1 U2SURP DLGAP5 TFIP11 HP1BP3 TWF1 GPALPP1 SCML2 BAZ2A KIAA1217 CIAPIN1 FEN1 ANKRD17 DDX21 NOP2 UTRN DNMT1 | 2.44e-06 | 978 | 125 | 20 | int:NAA40 |
| Interaction | DOT1L interactions | TCOF1 ZC3H13 U2SURP POLRMT TFIP11 INO80 KRR1 AHDC1 HP1BP3 OSBPL3 A2ML1 FEN1 AFF1 SLC25A11 HADHB DDX21 NOP2 ELL | 2.48e-06 | 807 | 125 | 18 | int:DOT1L |
| Interaction | MYCN interactions | NOLC1 TCOF1 ZC3H13 U2SURP TUT7 TFIP11 DPF2 PTBP1 KRR1 HP1BP3 NCBP3 NFX1 ANKRD17 AKAP13 ISG20L2 SLC25A11 HADHB SPATS2 DDX21 NOP2 ALOX12 RAI1 TP73 DNMT1 | 3.32e-06 | 1373 | 125 | 24 | int:MYCN |
| Interaction | MEN1 interactions | NOLC1 TCOF1 ZC3H13 U2SURP POLRMT TFIP11 INO80 KRR1 AHDC1 HP1BP3 NCBP3 SCML2 BAZ2A OSBPL3 ANKRD17 SLC25A11 HADHB SPATS2 DDX21 NOP2 | 5.24e-06 | 1029 | 125 | 20 | int:MEN1 |
| Interaction | H2BC8 interactions | DLGAP5 DPF2 CDCA8 HP1BP3 NCBP3 GPALPP1 SCML2 TRMT6 ZSCAN21 BAZ2A FEN1 MGA RAI1 DNMT1 | 1.38e-05 | 576 | 125 | 14 | int:H2BC8 |
| Interaction | SIRT7 interactions | NOLC1 TCOF1 ZC3H13 U2SURP TUT7 POLRMT KRR1 HP1BP3 BAZ2A ANKRD17 LTF DDX21 NOP2 UTRN RAI1 DNMT1 | 1.49e-05 | 744 | 125 | 16 | int:SIRT7 |
| Interaction | CHD3 interactions | NOLC1 ZC3H13 U2SURP TFIP11 PTBP1 KRR1 HP1BP3 NCBP3 NFX1 LTF SPATS2 UHRF2 DDX21 NOP2 RAI1 TP73 | 1.84e-05 | 757 | 125 | 16 | int:CHD3 |
| Interaction | RPL31 interactions | NOLC1 TCOF1 ZC3H13 U2SURP TUT7 KRR1 CDCA8 NCBP3 ZSCAN21 BAZ2A FEN1 NFX1 ISG20L2 DDX21 NOP2 | 2.09e-05 | 680 | 125 | 15 | int:RPL31 |
| Interaction | USP36 interactions | NOLC1 U2SURP POLRMT PTBP1 KRR1 HP1BP3 USP42 ISG20L2 HADHB LTF SPATS2 DDX21 NOP2 SLX4 | 2.13e-05 | 599 | 125 | 14 | int:USP36 |
| Interaction | CENPA interactions | ZC3H13 CDCA8 HP1BP3 NCBP3 ZSCAN21 BAZ2A FEN1 ISG20L2 NOP2 RAI1 DNMT1 | 2.34e-05 | 377 | 125 | 11 | int:CENPA |
| Interaction | GSK3A interactions | FAM193B U2SURP APC PTBP1 AHDC1 NHSL1 ROBO1 SLC25A11 LTF BRSK1 UTRN SLX4 | 3.23e-05 | 464 | 125 | 12 | int:GSK3A |
| Interaction | HECTD1 interactions | NOLC1 U2SURP TUT7 POLRMT APC PTBP1 KRR1 CDCA8 HP1BP3 NCBP3 SH3PXD2A ISG20L2 SLC25A11 SPATS2 DDX21 NOP2 UTRN DNMT1 | 3.65e-05 | 984 | 125 | 18 | int:HECTD1 |
| Interaction | SLIT3 interactions | 3.71e-05 | 11 | 125 | 3 | int:SLIT3 | |
| Interaction | SRPK2 interactions | NOLC1 TCOF1 ZC3H13 U2SURP POLRMT TFIP11 PTBP1 KRR1 HP1BP3 CLASRP NCBP3 AKAP13 CPLANE1 DDX21 NOP2 | 3.85e-05 | 717 | 125 | 15 | int:SRPK2 |
| Interaction | H3-3A interactions | ASH1L INO80 CDCA8 HP1BP3 NCBP3 SCML2 TRMT6 ZSCAN21 BAZ2A FEN1 HADHB UHRF2 MGA RAI1 DNMT1 | 6.31e-05 | 749 | 125 | 15 | int:H3-3A |
| Interaction | DAXX interactions | NOLC1 TFIP11 KRR1 HP1BP3 HADHB GOLGA6L9 SLX4 RAI1 TP73 DNMT1 | 7.14e-05 | 353 | 125 | 10 | int:DAXX |
| Interaction | CAMKV interactions | 9.44e-05 | 118 | 125 | 6 | int:CAMKV | |
| Interaction | ZNF330 interactions | NOLC1 CDCA8 HP1BP3 NCBP3 TRMT6 ZSCAN21 FEN1 DDX21 NOP2 RAI1 DNMT1 | 1.06e-04 | 446 | 125 | 11 | int:ZNF330 |
| Interaction | NUP43 interactions | ZC3H13 ASH1L APC INO80 CDCA8 AHDC1 HP1BP3 NCBP3 TDRD7 GPALPP1 BAZ2A MGA SLX4 | 1.38e-04 | 625 | 125 | 13 | int:NUP43 |
| Interaction | EGLN3 interactions | FAM193B HAUS6 DLGAP5 APC TATDN2 NKIRAS2 NHSL1 PIK3C2A OSBPL3 N4BP2 CIAPIN1 RAD54B ANKRD17 ROBO1 AKAP13 SLC25A11 HADHB MGA UTRN SLX4 | 1.38e-04 | 1296 | 125 | 20 | int:EGLN3 |
| Interaction | CBX8 interactions | 1.65e-04 | 249 | 125 | 8 | int:CBX8 | |
| Interaction | DHX40 interactions | 1.65e-04 | 249 | 125 | 8 | int:DHX40 | |
| Interaction | SUZ12 interactions | NOLC1 ZC3H13 PTBP1 KRR1 AHDC1 HP1BP3 NCBP3 USP42 N4BP2 SLC25A11 UHRF2 NOP2 DNMT1 | 1.85e-04 | 644 | 125 | 13 | int:SUZ12 |
| Interaction | CBX3 interactions | TCOF1 ZC3H13 CDCA8 AHDC1 HP1BP3 SCML2 ZSCAN21 BAZ2A FEN1 UHRF2 MGA SLX4 DNMT1 | 1.91e-04 | 646 | 125 | 13 | int:CBX3 |
| Interaction | PRKRA interactions | 1.98e-04 | 400 | 125 | 10 | int:PRKRA | |
| Interaction | DDX23 interactions | NOLC1 TCOF1 ZC3H13 U2SURP TFIP11 PTBP1 CLASRP GPALPP1 DDX21 NOP2 TP73 | 2.02e-04 | 480 | 125 | 11 | int:DDX23 |
| Interaction | FGFBP1 interactions | 2.04e-04 | 257 | 125 | 8 | int:FGFBP1 | |
| Interaction | RPL11 interactions | NOLC1 BDP1 TCOF1 KRR1 HP1BP3 USP42 OSBPL3 NFX1 ANKRD17 DDX21 NOP2 SLX4 TP73 | 2.09e-04 | 652 | 125 | 13 | int:RPL11 |
| Interaction | HDAC4 interactions | KALRN ADGRB3 APC TFIP11 INO80 GPALPP1 SH3PXD2A NFX1 SLC25A11 SPATS2 GOLGA6L9 DDX21 NOP2 DNMT1 | 2.15e-04 | 744 | 125 | 14 | int:HDAC4 |
| Interaction | CHD4 interactions | NOLC1 TCOF1 U2SURP TFIP11 DPF2 PTBP1 KRR1 HP1BP3 NCBP3 BAZ2A LTF DDX21 NOP2 SLX4 RAI1 DNMT1 | 2.28e-04 | 938 | 125 | 16 | int:CHD4 |
| Interaction | BMI1 interactions | ZC3H13 TFIP11 DPF2 PTBP1 KRR1 HP1BP3 NCBP3 SCML2 NFX1 SLC25A11 UHRF2 MGA NOP2 | 2.32e-04 | 659 | 125 | 13 | int:BMI1 |
| Interaction | ADARB1 interactions | TCOF1 U2SURP TUT7 TFIP11 PTBP1 TCEANC HP1BP3 SCML2 FEN1 DDX21 NOP2 | 2.37e-04 | 489 | 125 | 11 | int:ADARB1 |
| Interaction | YWHAG interactions | NOLC1 PHACTR2 ZC3H13 BAD APC KRR1 RGS12 TWF1 NHSL1 NKD2 PIK3C2A SH3PXD2A OSBPL3 N4BP2 ANKRD17 AKAP13 KIF13A UTRN DNMT1 | 2.46e-04 | 1248 | 125 | 19 | int:YWHAG |
| Interaction | S100A2 interactions | FAM193B HAUS6 PAXX POLRMT CDCA8 TDRD7 NHSL1 SPATS2 BRSK1 RAI1 | 2.51e-04 | 412 | 125 | 10 | int:S100A2 |
| Interaction | KIF20A interactions | NOLC1 POLRMT TFIP11 DPF2 PTBP1 KRR1 TCEANC CDCA8 RGS12 TWF1 PIK3C2A AFF1 HADHB KIF13A DDX21 NOP2 UTRN | 2.71e-04 | 1052 | 125 | 17 | int:KIF20A |
| Interaction | PRNP interactions | MYLK ASH1L APC DPF2 KRR1 TWF1 NHSL1 TRMT6 NECAP2 NKD2 USP42 OSBPL3 FEN1 AKAP13 HADHB ATP1B1 MGA NOS1 | 2.83e-04 | 1158 | 125 | 18 | int:PRNP |
| GeneFamily | PHD finger proteins | 1.54e-06 | 90 | 72 | 6 | 88 | |
| GeneFamily | Beta-1,3-glucuronyltransferases | 4.68e-05 | 3 | 72 | 2 | 423 | |
| GeneFamily | Tudor domain containing | 4.27e-04 | 37 | 72 | 3 | 780 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 5.53e-04 | 9 | 72 | 2 | 1280 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.36e-06 | 188 | 130 | 7 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.51e-06 | 191 | 130 | 7 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.62e-06 | 193 | 130 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.80e-06 | 196 | 130 | 7 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.92e-06 | 198 | 130 | 7 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 2.06e-06 | 200 | 130 | 7 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_endoneurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.34e-06 | 145 | 130 | 6 | e808502fa52baf1c400f3c9b918a167127e78af9 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 7.91e-06 | 161 | 130 | 6 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.79e-06 | 164 | 130 | 6 | 5621c2e3fae84d5a2e4f1595e454bcb3a2b3f93c | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 176 | 130 | 6 | 29cda51a99100ddd2928cadc92da40f001d7e1f4 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 176 | 130 | 6 | 01774a86d7d92f31a056b753f9844f923038003e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-05 | 177 | 130 | 6 | 9b02fd91c110b405eba6cb74ceb90b1286535973 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 1.49e-05 | 180 | 130 | 6 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 1.64e-05 | 183 | 130 | 6 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.97e-05 | 189 | 130 | 6 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-05 | 192 | 130 | 6 | dc40ef2341e5d6a6d479f140e023fe1bf687928d | |
| ToppCell | 368C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.21e-05 | 193 | 130 | 6 | 5f5904cec8b2967154ef2eab3c48f51df53aca4a | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.21e-05 | 193 | 130 | 6 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.28e-05 | 194 | 130 | 6 | 83863da11dfbe59b2d0a2c08db40b537c150588c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.28e-05 | 194 | 130 | 6 | 1bcb3fafd498614f7bac2b1c9b7de56e39110f65 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.28e-05 | 194 | 130 | 6 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.41e-05 | 196 | 130 | 6 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.48e-05 | 197 | 130 | 6 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.48e-05 | 197 | 130 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 2.48e-05 | 197 | 130 | 6 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.48e-05 | 197 | 130 | 6 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 2.55e-05 | 198 | 130 | 6 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 2.55e-05 | 198 | 130 | 6 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.55e-05 | 198 | 130 | 6 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.63e-05 | 199 | 130 | 6 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | TCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.63e-05 | 199 | 130 | 6 | 38f1f612b29feb868322999ceeda78e52447ec4f | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.63e-05 | 199 | 130 | 6 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.63e-05 | 199 | 130 | 6 | b10698aee2e6c17bc559eb4f723024141f914b90 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.70e-05 | 200 | 130 | 6 | e504570fd7eec1524c401b1cfa9d10822d80d994 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-05 | 200 | 130 | 6 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.70e-05 | 200 | 130 | 6 | 6a44439e4a7ce3627271375b04cfcfb9467218f4 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.70e-05 | 200 | 130 | 6 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.70e-05 | 200 | 130 | 6 | 8d51b4f7b7002ee51401ebe5eaca1e8f04bfadd5 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-05 | 200 | 130 | 6 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Neuronal-Excitatory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.70e-05 | 200 | 130 | 6 | 4409065bc7aa995354c71e0f9d6f3726cf393d6b | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.70e-05 | 200 | 130 | 6 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A--L4-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.70e-05 | 200 | 130 | 6 | cb1f4b0d66da5b0466ff17b29e7034d451d93e4f | |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 2.70e-05 | 200 | 130 | 6 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| ToppCell | E16.5-samps|World / Age Group, Lineage, Cell class and subclass | 7.64e-05 | 149 | 130 | 5 | e94d075f68c1c70c89fab50b1b765b5dda650d09 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.66e-05 | 153 | 130 | 5 | 65641cc82883716dba0fefb749a30174a63f4da5 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.66e-05 | 153 | 130 | 5 | d3fb83ca984c7583b1e51c364be6c7c17f67b048 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 1.04e-04 | 159 | 130 | 5 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.07e-04 | 160 | 130 | 5 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 161 | 130 | 5 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 1.10e-04 | 161 | 130 | 5 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 1.20e-04 | 164 | 130 | 5 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.23e-04 | 165 | 130 | 5 | f37fd95adc95d7753cf6e55ae819976513c7ec77 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-dnT|ICU-SEP / Disease, Lineage and Cell Type | 1.27e-04 | 166 | 130 | 5 | 96d92316cee20b722fe782db9dafcceb8f2c220b | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|World / disease group, cell group and cell class (v2) | 1.31e-04 | 167 | 130 | 5 | bf08f17965a4dd03f371b4ed0ab0d5e62ed61307 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-04 | 167 | 130 | 5 | 55c3c68af269fcf40f2b080ae4489523609ad388 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-04 | 171 | 130 | 5 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 1.46e-04 | 171 | 130 | 5 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.50e-04 | 172 | 130 | 5 | 282017db72d0537ac82aecc69393ccde9590be60 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.54e-04 | 173 | 130 | 5 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 176 | 130 | 5 | e9152defb4fd41267fb33c42c01fd0c683280783 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 176 | 130 | 5 | a4d269075aa0efc46fa251b379f334e50c69391d | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 176 | 130 | 5 | 7292e014b8f697f0c2e9f47c48333de95cb44a69 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 176 | 130 | 5 | cc6f65a7d2c622841c9d1ab3755586039d4ccc4d | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.67e-04 | 176 | 130 | 5 | 4ed73c73972334f6dc4229920205547823252fa0 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 176 | 130 | 5 | 88ca2f83d8301633232735f39b0683efe49d0b86 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-04 | 178 | 130 | 5 | f2002a5c4758d0af6c1880ca12f0af0d5e8888e4 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.81e-04 | 179 | 130 | 5 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 179 | 130 | 5 | 479116ac65488c60104a053530830763ec1f95b2 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 179 | 130 | 5 | 1dfc0cb8b369aef35c59f3d4c52603dc9f3728c1 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.81e-04 | 179 | 130 | 5 | 747a32460b257fffca30527b56a74720eb9c12e4 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 179 | 130 | 5 | 54621d2b3a66e62aa76b7e444118878ed97c1e02 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 179 | 130 | 5 | 69a1b3b05c921de6343ffe6ad998aa2b804312a7 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.81e-04 | 179 | 130 | 5 | ce3ca7f3a5864e62307aa744a3173f350a90df28 | |
| ToppCell | RSV-Healthy-0|RSV / Virus stimulation, Condition and Cluster | 1.85e-04 | 180 | 130 | 5 | 974044056e2f7e909cb11c6f6ca89e58bf95f7e5 | |
| ToppCell | mild_COVID-19_(asymptomatic)-cDC|World / disease group, cell group and cell class (v2) | 1.85e-04 | 180 | 130 | 5 | 68d1c867734fb2977b01ac686b20bf602f9a6b72 | |
| ToppCell | RSV-Healthy-0|Healthy / Virus stimulation, Condition and Cluster | 1.85e-04 | 180 | 130 | 5 | 703a1d0f9536af94d56757eb01221878d7b7fe61 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 181 | 130 | 5 | 269b39ac65790061d54eab47a8eeb024403f0348 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 181 | 130 | 5 | cd4f744b6b64ba6c22ec07afd1d3058a2546909d | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 181 | 130 | 5 | c8395ae872aa80b3ae1ab7c53e57b3ca15aeb0e2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.90e-04 | 181 | 130 | 5 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 1.95e-04 | 182 | 130 | 5 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-04 | 182 | 130 | 5 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.00e-04 | 183 | 130 | 5 | 61a73de857f4ae02dcba3af348f436f602b28ff2 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.00e-04 | 183 | 130 | 5 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 184 | 130 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.05e-04 | 184 | 130 | 5 | a0831e850bc0b585296ed350fdd075c1f730308e | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 184 | 130 | 5 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | 21-Trachea-Mesenchymal-Airway_Smooth_Muscle|Trachea / Age, Tissue, Lineage and Cell class | 2.05e-04 | 184 | 130 | 5 | 86a96cd88e50eacad1f0badfbbf6dc626f41725e | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-04 | 186 | 130 | 5 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.16e-04 | 186 | 130 | 5 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.16e-04 | 186 | 130 | 5 | 993c58ef4445bf81bbc9b489635883848b5b4c8e | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-04 | 186 | 130 | 5 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-04 | 186 | 130 | 5 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.16e-04 | 186 | 130 | 5 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-04 | 186 | 130 | 5 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.16e-04 | 186 | 130 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.21e-04 | 187 | 130 | 5 | 218c9b4f28499389c43005d9626af2ac01066027 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 2.21e-04 | 187 | 130 | 5 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.21e-04 | 187 | 130 | 5 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.21e-04 | 187 | 130 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| Disease | adenoma (is_implicated_in) | 1.59e-05 | 2 | 118 | 2 | DOID:657 (is_implicated_in) | |
| Disease | Hematochezia | 9.46e-05 | 4 | 118 | 2 | C0018932 | |
| Disease | trochanter size | 1.57e-04 | 5 | 118 | 2 | EFO_0010074 | |
| Disease | Endometrial Stromal Sarcoma | 1.57e-04 | 5 | 118 | 2 | C0206630 | |
| Disease | Clear cell sarcoma of kidney | 2.35e-04 | 6 | 118 | 2 | C0334488 | |
| Disease | Treacher Collins syndrome (implicated_via_orthology) | 2.35e-04 | 6 | 118 | 2 | DOID:2908 (implicated_via_orthology) | |
| Disease | Gastrointestinal Hemorrhage | 5.60e-04 | 9 | 118 | 2 | C0017181 | |
| Disease | Glaucoma | 5.60e-04 | 9 | 118 | 2 | C0017601 | |
| Disease | Childhood Medulloblastoma | 6.85e-04 | 43 | 118 | 3 | C0278510 | |
| Disease | Melanotic medulloblastoma | 6.85e-04 | 43 | 118 | 3 | C1275668 | |
| Disease | Medullomyoblastoma | 6.85e-04 | 43 | 118 | 3 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 6.85e-04 | 43 | 118 | 3 | C0751291 | |
| Disease | Adult Medulloblastoma | 6.85e-04 | 43 | 118 | 3 | C0278876 | |
| Disease | Anxiety States, Neurotic | 7.33e-04 | 44 | 118 | 3 | C0376280 | |
| Disease | Anxiety neurosis (finding) | 7.33e-04 | 44 | 118 | 3 | C1279420 | |
| Disease | Anxiety Disorders | 7.33e-04 | 44 | 118 | 3 | C0003469 | |
| Disease | hematocrit | KALRN ASH1L PTBP1 CTDSP2 ANKRD17 CHRDL1 AFF1 UHRF2 NYAP1 ELL RAI1 TDRD12 | 7.48e-04 | 1011 | 118 | 12 | EFO_0004348 |
| Disease | prostatic hypertrophy (is_marker_for) | 8.52e-04 | 11 | 118 | 2 | DOID:11132 (is_marker_for) | |
| Disease | colon cancer (implicated_via_orthology) | 8.52e-04 | 11 | 118 | 2 | DOID:219 (implicated_via_orthology) | |
| Disease | urate measurement, bone density | 8.75e-04 | 619 | 118 | 9 | EFO_0003923, EFO_0004531 | |
| Disease | Neurobehavioral Manifestations | 1.02e-03 | 12 | 118 | 2 | C0525041 | |
| Disease | Medulloblastoma | 1.07e-03 | 50 | 118 | 3 | C0025149 | |
| Disease | Congenital Hypothyroidism | 1.20e-03 | 13 | 118 | 2 | C0010308 | |
| Disease | impotence (implicated_via_orthology) | 1.61e-03 | 15 | 118 | 2 | DOID:1875 (implicated_via_orthology) | |
| Disease | level of Sterol ester (27:1/18:1) in blood serum | 1.83e-03 | 16 | 118 | 2 | OBA_2045195 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.39e-03 | 139 | 118 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | monocyte count | KALRN U2SURP ASH1L AHDC1 EHD3 ATF6 RNF216 AKAP13 NYAP1 DISP1 ELL RAI1 DNMT1 | 2.42e-03 | 1320 | 118 | 13 | EFO_0005091 |
| Disease | renal cell carcinoma (is_implicated_in) | 2.70e-03 | 69 | 118 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | unipolar depression, bipolar disorder, schizophrenia | 2.87e-03 | 20 | 118 | 2 | EFO_0003761, MONDO_0004985, MONDO_0005090 | |
| Disease | Schizophrenia | APC RGS12 SH3PXD2A SLIT3 B3GAT1 NOS1 ALOX12 B3GAT2 RAI1 DNMT1 | 2.92e-03 | 883 | 118 | 10 | C0036341 |
| Disease | Joubert syndrome 1 | 3.17e-03 | 21 | 118 | 2 | C4551568 | |
| Disease | platelet component distribution width | 3.37e-03 | 755 | 118 | 9 | EFO_0007984 | |
| Disease | Prostatic Neoplasms | 3.39e-03 | 616 | 118 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.39e-03 | 616 | 118 | 8 | C0376358 | |
| Disease | Parkinson's disease (is_implicated_in) | 3.54e-03 | 76 | 118 | 3 | DOID:14330 (is_implicated_in) | |
| Disease | Alzheimer's disease (is_marker_for) | 3.80e-03 | 257 | 118 | 5 | DOID:10652 (is_marker_for) | |
| Disease | prostate carcinoma (is_marker_for) | 3.80e-03 | 23 | 118 | 2 | DOID:10286 (is_marker_for) | |
| Disease | Malignant tumor of colon | 3.87e-03 | 159 | 118 | 4 | C0007102 | |
| Disease | Malignant neoplasm of breast | AKAP6 KALRN PANX2 SLAMF1 CLASRP N4BP2 AFF1 ROBO1 HADHB TP73 DNMT1 | 3.90e-03 | 1074 | 118 | 11 | C0006142 |
| Disease | Unipolar Depression | 3.92e-03 | 259 | 118 | 5 | C0041696 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KPVLVNEGKKGFTDP | 316 | Q9P2W7 | |
| FQRPKPNLSRAGKKS | 616 | A6H8Y1 | |
| GRLQKPKPNAGKAAE | 706 | A6H8Y1 | |
| PGLRKKLKRSNPFNE | 2536 | A6H8Y1 | |
| GLVTKDPGKKPVFNA | 281 | Q9NR48 | |
| NRVLGFKPKPPKNES | 181 | P05026 | |
| VGKLCPKNFEGPSKT | 91 | P61568 | |
| LGKKVQFRKPAPGAT | 156 | P55199 | |
| IKEIFCPKKSNGRPN | 996 | P26358 | |
| KKGLPRPKSAGTATQ | 126 | Q92934 | |
| RRVFPTNFPGLQKKG | 131 | O60242 | |
| EFTQKPGFPKRGQKR | 1731 | Q9UIF9 | |
| GFVPQKGRSDTLIKP | 886 | A8K2U0 | |
| KKKNKTSRSQPGDGP | 2786 | Q12802 | |
| GKKPNFEVGSSRQLK | 161 | Q6FI81 | |
| QKKSPKPVCGNGRLE | 386 | Q8TC27 | |
| GPRNKTENGLTPKKK | 156 | P18850 | |
| RGGAAAKAKFIPKPQ | 1286 | Q5TGY3 | |
| PNGKLTVASPKRGQK | 1701 | O75179 | |
| EDNGNPLNPKSKGKL | 796 | Q96F81 | |
| PFKVPGKDTVTKDNG | 266 | P55084 | |
| PGKAASVKQRGSKPA | 466 | Q5SSJ5 | |
| GSKPAPKVSAAQRGK | 476 | Q5SSJ5 | |
| APSQLQGNSFKKPKF | 6 | Q9Y620 | |
| QGNSFKKPKFIPPGR | 11 | Q9Y620 | |
| QPGGTALAPKKRSRK | 1436 | Q7Z5J4 | |
| GGKGFKLRRQPSEPK | 176 | Q9UL26 | |
| PKQPVGGGQKLLTRK | 406 | Q14978 | |
| GGNFKPDTLKPKEVV | 1251 | Q9ULG1 | |
| QTGVGSKSKLKFLPP | 591 | Q92932 | |
| PGESLINPGFKSKKP | 181 | Q9BUH6 | |
| PATPDFRSVLGGKKK | 976 | Q15746 | |
| GQTGGLTQPKKDEPK | 81 | P43026 | |
| FLGLGQPRSPKSKRK | 16 | Q9UHF5 | |
| GRPPKNTGKSLISTK | 626 | Q8IWI9 | |
| TNRPGKNLKAFVPAK | 1511 | Q8IWI9 | |
| PKPNRAKSLGKAGTT | 506 | Q5JYT7 | |
| QPSPTGKDRKQGGRK | 756 | O60303 | |
| PPSKKRTQSIQGKGK | 146 | Q53HL2 | |
| VFLKSVSPANGKGKP | 871 | Q5SYE7 | |
| PSQLRNFKTPGKLKE | 576 | Q92824 | |
| PDSNKQRKGPEALGK | 776 | O00443 | |
| NTGKNEATGPRKPKD | 2416 | O60229 | |
| EATGPRKPKDILGNK | 2421 | O60229 | |
| ERRGFLSKKNQPPSK | 36 | Q9H9L3 | |
| KNRIGNKLPPEKFAD | 451 | Q53F19 | |
| ADPRGAKPKKATQFV | 161 | Q12986 | |
| PQSKSAFPLSRKNKG | 171 | Q9NYR9 | |
| KLNIKRNPFPKPGES | 171 | Q8N456 | |
| NSGKERSFQAKPSPK | 261 | Q8TB73 | |
| KGAGKSEFRNQKPKP | 11 | Q13601 | |
| PAGANRKKKINGSSP | 41 | A6NEY3 | |
| PAGANRKKKINGSSP | 41 | A6NEF3 | |
| PAGANRKKKINGSSP | 41 | A6NEM1 | |
| PAGANRKKKVNGSSP | 41 | A6NI86 | |
| PAGANRKKKVNGSSP | 41 | H0YKK7 | |
| AGSQTPPFKRKGKLS | 21 | O75167 | |
| SGPKPKAVLNQFRTD | 616 | P18054 | |
| PEKQFLKSPKGSGKP | 326 | Q969F2 | |
| DKPGARTLKSEPGKQ | 846 | Q6NV74 | |
| GIDGKPRTSPKSVKF | 11 | Q02978 | |
| NGSPSKCPRFLKVKN | 296 | P29475 | |
| KNGAASKRAFKQSPP | 321 | O15350 | |
| ERPFQLPPGKGKSKT | 316 | A1A4V9 | |
| DGKPPQLKSGELAKR | 86 | P39748 | |
| SQGLPKPEFRFKGQS | 2651 | Q9H799 | |
| VCPGKKAKELPGQSF | 321 | Q9BU40 | |
| EPVSSGGKPQKGKRQ | 706 | Q96PV7 | |
| QGLVSKSSPKKPRGR | 21 | O14595 | |
| SNPKAVFKRRGSQPG | 256 | Q9NPZ5 | |
| QPLRAKGKRPKDTFN | 6 | P0C843 | |
| PPGFIKSTQKSDKGR | 116 | Q8IXQ4 | |
| GRPAKNVETKPDKGI | 246 | Q15398 | |
| RGPPKDKKLLATNGT | 761 | Q8TDC3 | |
| FGGSLPAKKSDPFQK | 521 | Q7Z4H7 | |
| GETREKSPKLKNGFP | 141 | Q9NR30 | |
| KEKTKPVPGYNNDTG | 196 | Q9BZW2 | |
| ISRKPNTRKQKNGFP | 1106 | O00411 | |
| GPPKFKQRQTRQFKS | 26 | P18545 | |
| RQFKSKPPKKGVQGF | 36 | P18545 | |
| KSKPRKRLEESQGGP | 931 | Q5VVW2 | |
| IGKDAKGTLQVPKPF | 281 | Q9H4L5 | |
| GRAPKIEKQIQSKGP | 171 | Q96RD6 | |
| PGKLLRKTFSQSPQG | 116 | Q86XP0 | |
| KKAGSQKPTPEGRES | 141 | Q6ZVC0 | |
| PSNTKQGERKPPKVF | 41 | Q9H1H9 | |
| RGLNLAPSPANKAKK | 806 | Q8IVF1 | |
| APSPANKAKKRPLFG | 811 | Q8IVF1 | |
| RGLNLAPSPANKAKK | 806 | A6NNL0 | |
| APSPANKAKKRPLFG | 811 | A6NNL0 | |
| RGLNLAPSPANKAKK | 806 | B1AL46 | |
| DKKKRKANTQGPSFP | 36 | Q9Y3Y4 | |
| EKRKNPFNSSKLPEG | 156 | Q9HCH5 | |
| INARFSKSGKPPIND | 41 | P46939 | |
| SGGPSSPKRLKAQKE | 46 | Q93075 | |
| KSPKFQLFGSPSGQK | 301 | P02788 | |
| GKQTGLEQKPKFSRS | 216 | Q17RD7 | |
| KPKKGAGNPQASTLA | 1276 | Q13428 | |
| DLKKALQRNKFPGPS | 426 | Q587J7 | |
| KPGPLQKKLDSFPAQ | 286 | Q13291 | |
| NRPGTLDKPGKQSKL | 1756 | Q5T5P2 | |
| KENGKKPGSFPTQLR | 426 | Q6ZUB0 | |
| KRKNGENTFKRIGPP | 756 | Q9NWF9 | |
| KKPNPAPLRDKGNSV | 136 | Q8NHU6 | |
| TGKGHFNIQPNKKSP | 156 | Q9UHQ9 | |
| KKGPQSLFNAPRGKK | 91 | P46087 | |
| VDPKKPFRKLNAFGN | 116 | Q9NZN3 | |
| GLETPKGANRKKNLP | 1541 | Q8IY92 | |
| DELESGKRPKKPGQS | 856 | O15042 | |
| GKRPKKPGQSFQEQV | 861 | O15042 | |
| GIPERQKGKPNVTSK | 1901 | Q13023 | |
| PPGKGSRQRKAEDKQ | 776 | P51825 | |
| SNKGPRILKPGEKST | 2161 | P25054 | |
| AGKETGAAKPKLTPQ | 561 | Q8N2M8 | |
| GANGAIKKRKPPVKF | 231 | Q6S5L8 | |
| KGTPKSLGKLQKQPA | 1256 | O75094 | |
| KGQSKKQPSGTTKRP | 651 | Q96PU4 | |
| KENGKKPGSFPTQLR | 426 | P0C874 | |
| FKKGLPQRKPRTSQT | 526 | Q86XZ4 | |
| KSKPSPQKDQALGDG | 71 | Q9H9J4 | |
| PKAKTRTLFGKDVPG | 56 | Q5EBM4 | |
| NEKGTKPPLQEAGSK | 246 | Q9Y5A6 | |
| KPPLQEAGSKKGRES | 251 | Q9Y5A6 | |
| PSRGKASADKQKGVP | 1106 | O14924 | |
| KLFPVRGNKEENSGP | 91 | Q8N8B7 | |
| VKNITPRKKGPNSGK | 301 | Q9UQR0 | |
| DKFPIEGGQKDPKQR | 56 | Q5TCZ1 | |
| GEFQFPPKSLNKREG | 146 | Q5T0D9 | |
| EQKSKKGPDGLALPN | 256 | Q92785 | |
| KGRGNKAAKRDLPPA | 1561 | Q9Y6N7 | |
| GGSLQPKKKREEPTA | 71 | Q9UJA5 | |
| KQSKDPLGKDPQEGT | 296 | Q9NZV7 | |
| NGSVPKSPGKVLKRT | 21 | Q13061 | |
| NRKTIGAKQFRGPDP | 36 | P35442 | |
| KRPKEAGPQGKATQA | 316 | Q53SZ7 | |
| LQKKKITPGNYGNTP | 51 | Q5VYS8 | |
| GNSPLHRFKKPGSKN | 431 | P26599 | |
| QAIPGTRSAIGKPKK | 711 | P01266 | |
| PRKLKTGGNFKPSQK | 116 | Q9UBB9 | |
| AAQQSKKKRGPRTPP | 1021 | Q5T200 | |
| QSFAKPKGPAGKRGI | 321 | Q12792 | |
| TGFRNNKNPKKPLTL | 91 | O14657 | |
| KNLGGNPFRKTANPK | 6 | Q86UW6 | |
| KKKEGAAGNPRVRPA | 166 | Q9NVZ3 |